What Researchers Did
Researchers conducted a review discussing promising new "out of the box" therapeutic strategies for Crohn's disease beyond current pharmacological treatments.
What They Found
The review highlighted that almost 50% of Crohn's disease patients do not achieve sustained response with current treatments, necessitating new approaches. Researchers discussed various non-pharmacological strategies including nutritional interventions, cell therapies, microbiota-based treatments, and neuromodulation as potential main or complementary therapies.
What This Means for Canadian Patients
Canadian patients with Crohn's disease who struggle with current treatments may benefit from the exploration of these novel "out of the box" therapies in the future. These strategies aim to improve treatment efficacy, minimize side effects, and enhance quality of life for those living with this chronic condition.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
As a review, this study synthesizes existing literature, and the discussed "out of the box" therapies require further robust clinical trials to establish their widespread efficacy.